News provided by Eli Lilly and Company May 21, 2026, 06:45 ET In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss, a level long associated with bariatric surgery Individuals with a baseline BMI 35 who participated in a study extension continued to lose weight, and achieved up to an average of 85.0 lbs (30.3%) weight loss at 104 weeks At the 4 mg dose, reached with only a single escalation step, participants lost an average of 47.2 lbs (19.0%) at 80 weeks with a lower observed discontinuation rate due to adverse events vs
She didnt swear off drinking
While there isnt a magic food that will dramatically increase GLP-1 (especially as much as a drug can), there are tremendous health and body composition benefits that come from consistently choosing balanced meals with enough protein, plenty of fibre, and some healthy fats
He holds fellowships in aesthetics and hair transplantation and has trained under renowned dermatologists and celebrity plastic surgeons
295 However, the large cardiovascular outcome trials of GLP-1R agonists have not found any obvious effects of these therapies on bone
Patient education should address both the expected benefits and potential adverse effects of semaglutide, with particular emphasis on gastrointestinal symptoms that may be difficult to distinguish from autoimmune disease manifestations